Prevalence and clinical significance of cryofibrinogenaemia in patients with renal disorders | Zendy

Benjamin Terrier | Zendy; Hassane Izzedine | Zendy; L. Musset | Zendy; P. Ghillani | Zendy; Gilbert Deray | Zendy; David Saadoun | Zendy; P. Cacoub | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prevalence and clinical significance of cryofibrinogenaemia in patients with renal disorders

Author(s) -

Benjamin Terrier,

Hassane Izzedine,

L. Musset,

P. Ghillani,

Gilbert Deray,

David Saadoun,

P. Cacoub

Publication year - 2011

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfr079

Subject(s) - medicine , renal function , thrombosis , gastroenterology , dialysis , nephrology , kidney disease , nephropathy , hemodialysis , creatinine , diabetes mellitus , endocrinology

Cryofibrinogenaemia (CryoFg) is an under-recognized cryoprotein that can be life-threatening when untreated. Symptoms are mainly thrombotic cutaneous manifestations, but other thrombotic localizations may occur. In patients with end-stage renal disease, thromboses are common. However, the implication of CryoFg was never assessed. The aim of this study is to describe the prevalence and the significance of CryoFg in patients with renal disorders.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research